GFAP and Alzheimer disease: Remarkably, Habib et al. (2020), using sNuc‐seq to study the transgenic mice model of AD (5 × FAD), found an additional astrocyte phenotype (besides the regular astrogliosis) characterized by a GFAP‐high content, which they termed disease‐associated astrocytes (DAAs).